Literature DB >> 12177296

A splicing silencer that regulates smooth muscle specific alternative splicing is active in multiple cell types.

Natalia Gromak1, Christopher W J Smith.   

Abstract

Alternative splicing of alpha-tropomyosin (alpha-TM) involves mutually exclusive selection of exons 2 and 3. Selection of exon 2 in smooth muscle (SM) cells is due to inhibition of exon 3, which requires both binding sites for polypyrimidine tract-binding protein as well as UGC (or CUG) repeat elements on both sides of exon 3. Point mutations or substitutions of the UGC-containing upstream regulatory element (URE) with other UGC elements disrupted the alpha-TM splicing pattern in transfected cells. Multimerisation of the URE caused enhanced exon skipping in SM and various non-SM cells. In the presence of multiple UREs the degree of splicing regulation was decreased due to the high levels of exon skipping in non-SM cell lines. These results suggest that the URE is not an intrinsically SM- specific element, but that its functional strength is fine tuned to exploit differences in the activities of regulatory factors between SM and other cell types. Co-transfection of tropomyosin reporters with members of the CUG-binding protein family, which are candidate URE-binding proteins, indicated that these factors do not mediate repression of tropomyosin exon 3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12177296      PMCID: PMC134246          DOI: 10.1093/nar/gkf480

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

Review 1.  SR proteins and splicing control.

Authors:  J L Manley; R Tacke
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

Review 2.  The SR protein family: pleiotropic functions in pre-mRNA splicing.

Authors:  J Valcárcel; M R Green
Journal:  Trends Biochem Sci       Date:  1996-08       Impact factor: 13.807

3.  Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon.

Authors:  C Gooding; G C Roberts; C W Smith
Journal:  RNA       Date:  1998-01       Impact factor: 4.942

4.  Smooth muscle alternative splicing induced in fibroblasts by heterologous expression of a regulatory gene.

Authors:  G C Roberts; C Gooding; C W Smith
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

5.  A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer.

Authors:  H Min; C W Turck; J M Nikolic; D L Black
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

6.  Multiple RRMs contribute to RNA binding specificity and affinity for polypyrimidine tract binding protein.

Authors:  I Pérez; J G McAfee; J G Patton
Journal:  Biochemistry       Date:  1997-09-30       Impact factor: 3.162

7.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.

Authors:  D Yaffe; O Saxel
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

8.  Mutation of PTB binding sites causes misregulation of alternative 3' splice site selection in vivo.

Authors:  I Pérez; C H Lin; J G McAfee; J G Patton
Journal:  RNA       Date:  1997-07       Impact factor: 4.942

9.  Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy.

Authors:  L T Timchenko; N A Timchenko; C T Caskey; R Roberts
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

10.  The generally expressed hnRNP F is involved in a neural-specific pre-mRNA splicing event.

Authors:  H Min; R C Chan; D L Black
Journal:  Genes Dev       Date:  1995-11-01       Impact factor: 11.361

View more
  9 in total

1.  Modulating alternative splicing by cotranscriptional cleavage of nascent intronic RNA.

Authors:  Natalia Gromak; Gabriele Talotti; Nicholas J Proudfoot; Franco Pagani
Journal:  RNA       Date:  2007-12-07       Impact factor: 4.942

2.  Exon selection in alpha-tropomyosin mRNA is regulated by the antagonistic action of RBM4 and PTB.

Authors:  Jung-Chun Lin; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

3.  Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein.

Authors:  Natalia Gromak; Arianne J Matlin; Thomas A Cooper; Christopher W J Smith
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

4.  The PTB interacting protein raver1 regulates alpha-tropomyosin alternative splicing.

Authors:  Natalia Gromak; Alexis Rideau; Justine Southby; A D J Scadden; Clare Gooding; Stefan Hüttelmaier; Robert H Singer; Christopher W J Smith
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

5.  Activation of alpha-tropomyosin exon 2 is regulated by the SR protein 9G8 and heterogeneous nuclear ribonucleoproteins H and F.

Authors:  J Barrett Crawford; James G Patton
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

6.  A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones.

Authors:  Clare Gooding; Francis Clark; Matthew C Wollerton; Sushma-Nagaraja Grellscheid; Harriet Groom; Christopher W J Smith
Journal:  Genome Biol       Date:  2006-01-13       Impact factor: 13.583

7.  MBNL1 and PTB cooperate to repress splicing of Tpm1 exon 3.

Authors:  Clare Gooding; Christopher Edge; Mike Lorenz; Miguel B Coelho; Mikael Winters; Clemens F Kaminski; Dmitry Cherny; Ian C Eperon; Christopher W J Smith
Journal:  Nucleic Acids Res       Date:  2013-03-19       Impact factor: 16.971

8.  Dissecting domains necessary for activation and repression of splicing by Muscleblind-like protein 1.

Authors:  Christopher Edge; Clare Gooding; Christopher W J Smith
Journal:  BMC Mol Biol       Date:  2013-12-27       Impact factor: 2.946

9.  FBXO22 degrades nuclear PTEN to promote tumorigenesis.

Authors:  Meng-Kai Ge; Na Zhang; Li Xia; Cheng Zhang; Shuang-Shu Dong; Zhan-Ming Li; Yan Ji; Min-Hua Zheng; Jing Sun; Guo-Qiang Chen; Shao-Ming Shen
Journal:  Nat Commun       Date:  2020-04-06       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.